logo

Last Update

This profile was last updated on 7/5/2017 and contains contributions from the  Zoominfo Community.

is this you? Claim your profile.

Wrong Akbar Khan?

Akbar N. Khan

Medical Director

Medicor Cancer Centres Inc

HQ Phone:  (416) 227-0037

Email: a***@***.com

GET ZOOMINFO GROW

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Medicor Cancer Centres Inc

4576 Yonge St Suite 301

Toronto, Ontario,M2N 6N4

Canada

Company Description

Medicor embraces and utilizes digital technology to the maximum extent possible. Technologies used range from routine electronic patient communication (email, SMS, video conferencing) to electronic record-keeping on our proprietary secure servers. ...more

Web References(96 Total References)


About - Medicor Cancer

medicorcancer.com [cached]

Akbar Khan, MD
Akbar Khan, MD Medical Director Dr. Akbar Khan is the founder and Medical Director of Medicor Cancer Centres. For the last 21 years his practice has consisted primarily of providing personalized care for a limited number of cancer patients. He has advanced the field of non-toxic cancer therapy and published his findings in various peer-reviewed medical journals. Dr. Khan is now involved in building an integrative Canada-wide cancer prevention strategy. Dr. Khan acts as medical advisor for the LDN Research Trust. MORE ABOUT DR. KHANakhan@medicorcancer.com


Akbar N. Khan MD | ldn2016

www.ldn2016.com [cached]

Akbar N. Khan MD
Dr. Khan is a graduate of the University of Toronto, Faculty of Medicine (1992). He completed his certification in Family Medicine in 1994 (also at University of Toronto). After completion of his family medicine training, he immediately joined a palliative home care team at his local hospital. This is how his focus on cancer patients began. In 1999, Dr. Khan co-founded P.A.L.I.N., a registered charitable corporation which addressed the growing needs of cancer patients requiring at-home symptom control and enhanced quality of life. In 2006, Dr. Khan co-founded Medicor Cancer Centres, the first integrated private cancer clinic of its kind in Canada. Since 2007, Dr. Khan gained international recognition and has been treating patients from all over the world. He is privileged to be the first doctor in the world to prescribe offlabel dichloroacetate (DCA) to treat cancer with positive results. As a result, he now has the most DCA experience of any physician in the world with over 1400 cancer patients treated as of October 2013. He is also the first in the world to demonstrate the curative potential of DCA when used as an adjuvant to chemotherapy or radiotherapy (one case published, second publication pending). Dr. Khan is regularly publishing ground-breaking cancer papers in peer-reviewed medical journals such as: Dr. Khan is actively involved in undergraduate and post-graduate teaching and has been regularly invited to present lectures on various topics in palliative medicine and cancer therapy since 2000.


DCA and Radiation Effect Complete Long Term Remission of Previously 'Incurable' Cancer - Martin C. Winer

www.martincwiner.com [cached]

This allowed physicians such as Dr. Akbar Khan of Medicor Cancer Centres (http://www.medicorcancer.com/) to prescribe the drug for an "off-label" use in cancer.


DCA and Avemar Show Clinical Promise against (CLL) Leukemia - Martin C. Winer

www.martincwiner.com [cached]

- Dr. Akbar Khan, Medicor Cancer Centres


Clean Living Research - Prevent Cancer

prevent-cancer.ca [cached]

and Akbar Khan, MD, Medicor Medical Director
Akbar Khan, MD Medicor Director, Medicor Cancer Centres CONNECT WITH TOSCA RENO


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory